A new study reveals important connections between lingering lung damage after COVID-19 and mental health issues like anxiety and depression. The research also demonstrates that simple at-home breathing exercises can improve both lung function and mood. Key facts: 1 in 3 patients in the study still had abnormal lung function 2 months after moderate COVID-19 …
Mood disorders like major depression and bipolar disorder affect millions worldwide. Existing treatments often fall short, highlighting the need for better options. An emerging possibility is anti-inflammatory drugs like celecoxib that may target the immune system abnormalities linked to these conditions. A new comprehensive review suggests celecoxib holds promise as an add-on treatment for major …
Depression is a growing mental health concern, especially among young adults. New AI-powered research offers a rapid, objective screening tool to identify those at high risk using eye tracking technology. This innovative approach could revolutionize early detection and intervention. Key Facts: Depression is the leading cause of disability worldwide, often starting in young adulthood. Early …
Depression affects over 300 million people globally. Current treatments have limited efficacy for many patients. Exciting new research highlights the potential of allopregnanolone agonists like brexanolone and zuranolone as more targeted, rapid-acting antidepressants. Key Facts: Allopregnanolone is a neurosteroid that regulates mood and is decreased in depression. Its agonists boost allopregnanolone activity. Brexanolone is the …
Major depressive disorder affects over 17 million American adults each year. For up to 30% of these patients, standard antidepressant medications fail to provide adequate symptom relief – a condition known as treatment-resistant depression (TRD). Now, new research suggests amphetamine-based stimulants like Adderall may be an effective augmentation strategy for TRD when other therapies have …
Vagus nerve stimulation (VNS) is an emerging form of brain stimulation showing promise for treating depression. Though still considered experimental, VNS has a long history dating back over 100 years. Recent advances are unlocking its potential as a new tool for mood disorders. Key Facts: VNS stimulates the vagus nerve, which connects to emotion regulation …
Suicide is a major public health problem, with over 700,000 people dying by suicide every year globally. Identifying factors that may indicate risk for suicidal thoughts and behaviors is an important area of research, as this could aid prevention and intervention efforts. Some studies have investigated whether asymmetric brain activity, as measured by electroencephalography (EEG), …
Deep brain stimulation (DBS), a surgical procedure that implants electrodes in the brain to deliver electrical stimulation, may offer hope for people with severe depression that has not responded to multiple treatments. However, larger and more rigorous studies are still needed to confirm its benefits and long-term safety. Key Facts: DBS targets areas of the …
Deep brain stimulation (DBS) is an emerging experimental therapy that has shown promise in treating patients with severe, treatment-resistant depression (TRD). Early research indicates DBS may help patients who have failed to respond to medications, psychotherapy, and other interventions. Key facts: DBS involves surgically implanting electrodes in specific brain regions to deliver mild electrical stimulation. …
A new study provides evidence that the psychedelic compound psilocybin has both immediate and lasting anti-inflammatory effects in healthy volunteers. The findings shed light on how psilocybin may improve mood, social behavior, and potentially treat depression. Key facts: Psilocybin decreased the inflammatory marker TNF-alpha immediately after administration. Seven days later, psilocybin reduced two other inflammatory …
